The p53 tumour-suppressor protein is tightly regulated through its association with the Hdm2 E3 ligase. Activation of p53 by DNA strand breaks is orchestrated by the ataxia-telangiectasia mutated (ATM) protein kinase and involves interruption of Hdm2-mediated p53 degradation. As part of this mechanism ATM itself, and the ATM-activated protein tyrosine kinase, c-Abl, inhibit Hdm2 function through phosphorylation of serine 395 and tyrosine 394 (Y394), respectively. In the present study, we have identified a novel target of c-Abl in the Hdm2 protein, tyrosine 276 (Y276). We show that c-Abl phosphorylates this residue in vitro and confirm that Y394 is a target of c-Abl. We also show that Y276 is phosphorylated in a c-Abl-dependent manner in cultured cells and provide evidence that Y276 is phosphorylated in response to DNA damage coincident with the activation of c-Abl. Finally, we show that Y276 phosphorylation stimulates interaction with ARF, leading to increased levels of nucleolar Hdm2 and decreased turnover of p53. These data establish Y276 as a physiological target of c-Abl that contributes functionally to the induction of p53.
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The p53 tumour-suppressor protein is a labile transcription factor that is stabilized and activated in response to genotoxic or hyperproliferative stress, leading to growth arrest, replicative senescence, or apoptosis (Lu, 2005) . p53 functions within an autoregulatory loop in which the oncogenic E3 ubiquitin ligase, Hdm2 (the human homologue of Mdm2), mediates the ubiquitylation, nuclear export and proteasome-dependent degradation of p53, while p53 positively regulates HDM2 expression (Harris and Levine, 2005) . Cellular stresses that induce p53 mainly target the p53-Hdm2 interaction leading to interruption of this loop and inhibition of p53 ubiquitylation and/or degradation. Mechanistically, this occurs through induction of covalent modifications on both Hdm2 and p53, or through altered proteinprotein interactions (Appella and Anderson, 2001; Meek and Knippschild, 2003; Lu, 2005) .
The c-Abl protein tyrosine kinase is phosphorylated and activated within the nucleus by ataxia-telangiectasia mutated (ATM) in response to genotoxic agents (Shaul and Ben-Yehoyada, 2005 ) and contributes to the induction of p53 through association with Hdm2 and phosphorylation of Y394, leading to inhibition of Hdm2-mediated p53 degradation and the onset of p53-dependent apoptosis (Sionov et al., 1999 (Sionov et al., , 2001 Goldberg et al., 2002) . The aim of the present study was to identify an additional c-Abl-targeted phosphorylation site(s) thought to be present in Hdm2 (Goldberg et al., 2002) and assess its contribution towards regulating Hdm2 function.
To investigate the phosphorylation of Hdm2 by c-Abl in vitro, a series of glutathione S-transferase (GST)-Hdm2 fusion proteins (designated MP1-MP5, Kurki et al. (2004) ) were used as substrates in protein kinase reactions. The data indicate that there are at least two phosphorylation sites within amino acids 203-282 (MP3) and 279-491 (MP4), respectively ( Figure 1a , lanes 4 and 6). Neither the GST portion of this molecule nor fusion proteins MP1 (amino acids 1-110) or MP2 (amino acids 108-203) were phosphorylated (lanes 1-3, respectively). Recombinant active c-Abl kinase also phosphorylated full-length Hdm2 in vitro (Figure 1a , lane 7). When immunoprecipitates of endogenous c-Abl from MCF-7 cell extracts were used as the source of protein kinase activity, identical results were obtained (data not shown). Phosphorylation of the GST-Hdm2 protein, MP5, (comprising amino acids 203-340 of Hdm2) by recombinant c-Abl over a 2 h time course (Figure 1b) indicated that the stoichiometry of phosphorylation was approximately one mole of phosphate per mole of protein, consistent with the phosphorylation of a single residue in this region. (Similar data were obtained when MP3 was used as substrate (data not shown).) Mutants of MP3 in which each of the three tyrosines in this region (Y259, Y276 or Y281) had been substituted individually by phenylalanine indicated that Y276 was the phospho-acceptor residue (Figure 1c ). Phosphopeptide analysis of wild-type MP3 or the Y276 mutant confirmed the absence of a single major phosphopeptide species from the mutant protein (Figure 1d) .
Comparison of GST-full-length Hdm2 with a Y276F mutant of this protein confirmed that Y276 can be phosphorylated in the context of the full-length human protein ( Figure 2a) . Notably, phosphorylation of the Y276F mutant was significantly reduced, but not abolished, consistent with the idea that c-Abl can phosphorylate other residues in Hdm2. Phosphopeptide analysis of MP4 mutants in which tyrosine residues 394 and 405 had been substituted by phenylalanine residues revealed two pairs of overlapping phosphopeptides (panel MP4). The lower pair of phosphopeptides was absent from the Y394 mutant (panel Y394) whereas the upper phosphopeptides were absent from the Y405 mutant (Y405 panel). These data indicate that Y394 and Y405 were phosphorylated by recombinant c-Abl in vitro and support previous findings that Y394 is a target of the c-Abl kinase (Goldberg et al., 2002) .
A Y394/405F double mutant in MP4 could not be phosphorylated by c-Abl in vitro (data not shown).
To determine whether Hdm2 is phosphorylated at Y276 by c-Abl in cultured cells, COS-7 cells were transiently transfected with plasmids expressing wildtype Hdm2 or a Y276 mutant of Hdm2, in the absence or presence of a plasmid expressing a modified form of the c-Abl kinase that is constitutively-active and exclusively nuclear (Barila et al., 2000) . Cell labelling with [ 32 P]orthophosphate followed by two-dimensional chymotryptic phosphopeptide mapping (Blattner et al., 2002) (Figure 3a) showed stimulation of a single phosphopeptide in wild-type Hdm2 from cells in which active nuclear c-Abl was present, consistent with the idea that c-Abl can phosphorylate Hdm2 in vivo; (compare panels 1 and 2). Notably, this novel phosphopeptide was absent when the Y276F mutant of Hdm2 was co-expressed with active nuclear c-Abl (panel 4). To explore these ideas further, H1299 cells were transfected The radioactive proteins were excised from the gel and quantitated in a liquid scintillation counter, from which the stoichiometry of phosphorylation was calculated (lower panel). (c) MP3 fusion protein, or mutants containing tyrosine to phenylalanine substitutions at residues 259, 276 or 281, were phosphorylated by recombinant c-Abl as described in the legend to (a). (d) Two-dimensional phosphopeptide maps of MP3 or the Y276F mutant of MP3. Phosphorylated proteins in (c) were transferred to a PDVF membrane then excised, digested with chymotrypsin, and separated in two-dimensions on cellulose thin layer plates (electrophoresis in the horizontal direction and chromatography in the vertical direction) as described elsewhere (Blattner et al., 2002) . Phosphopeptides were loaded at the bottom left hand side of each map. The arrow indicates the position of the major phosphopeptide, absent from the Y276 map. In these and all subsequent peptide maps, the origins are marked by arrowheads. Similarly, substitution of tyrosines 394 and/or 405 also reduced the level of phospho-tyrosine present in Hdm2 (Figure 3b) .
To investigate the phosphorylation of Y276 in greater depth, a Y276-P phospho-specific antibody was developed. This antibody recognized c-Abl-phosphorylated, but not unphosphorylated MP3 (Figure 3c , right hand panel) and detected stimulation of Hdm2-Y276 phosphorylation in H1299 cells following co-expression of constitutively-active nuclear c-Abl (Figure 3c , left hand panels). To examine endogenous Hdm2 phosphorylation, MCF-7 cells were unstimulated, or stimulated for up to 12 h with the DNA damage-inducing drug, mitomycin C. This treatment resulted in a transient stimulation of c-Abl kinase activity accompanied by induction of the p53 protein (Figure 3d ). Y276 phosphorylation of endogenous Hdm2 was detected transiently 4 h after stimulation, coincident with the activation of endogenous c-Abl (Figure 3d , left hand middle panel). We suspect the weak signal obtained in this experiment is a reflection of the low levels of endogenous Hdm2 in the cells (as compared with the overexpression experiments described above). These data support the idea that c-Abl phosphorylates Hdm2 at Y276 physiologically in response to DNA damage.
To determine whether phosphorylation of Y276 can influence the ability of Hdm2 to mediate the turnover of p53, H1299 cells were transfected with plasmids expressing p53, constitutively-active nuclear c-Abl and either wild-type or Y276F mutant Hdm2. At 48 h after transfection, the decay of p53 and Hdm2 was assessed by cycloheximide chase (Figure 4a and b) . The data indicate that the turnover of the wild-type and Y276 mutant Hdm2 proteins was essentially indistinguishable. In contrast, however, a small but reproducible change in the Hdm2-mediated turnover of p53 was observed. Thus, under the conditions of transient ectopic expression used, the turnover of p53 was approximately 4.5 h in the presence of wild-type Hdm2, but just under 3 h when the Y276F Hdm2 was present. These data are consistent with the idea that phosphorylation of Y276 by c-Abl contributes towards inhibiting the ability of Hdm2 to degrade p53. The Y276 phosphorylation site lies within a short region that is important for binding to the critical Hdm2 regulator, p14ARF (Bothner et al., 2001) . To determine whether phosphorylation by c-Abl could affect the ARF-Hdm2 interaction, wild-type Hdm2 or the Y276F mutant were co-expressed with ARF and active or inactive nuclear c-Abl, and the amount of Hdm2-associated ARF was determined following immunoprecipitation of Hdm2 (Figure 4c ). The data show that elevated c-Abl activity led to an increase in ARF binding. In contrast, the inactive c-Abl protein almost abolished Hdm2-ARF binding, most likely by behaving in a dominant-negative manner to interfere with endogenous c-Abl function. These effects were not seen with the Y276F mutant underscoring their dependence upon the presence of the Y276 phosphorylation site. These data are consistent with the idea that the increased stabilization of p53 (Figure 4a and b) occurs through ARF-mediated downregulation of Hdm2 function. ARF drives p53 stabilization through multiple contributing mechanisms including sequestration of Hdm2 in the nucleolus (Michael and Oren, 2003) . While co-expression of Hdm2 with ARF led to the sequestration of Hdm2 in the nucleolus, nucleolar localization of the Y276F mutant was significantly weaker or, in some cells, absent (Figure 4d ). These observations support the idea that phosphorylation of Y276 stimulates Hdm2-ARF interaction.
In the present study, we have identified Y276 as an additional and novel site of c-Abl-mediated phosphorylation in Hdm2. This site is highly conserved (it is present in mammalian, chicken, xenopus and zebrafish Mdm2) and shares key features of several physiological and good synthetic c-Abl substrates (Wu et al., 2002) . Y276 is phosphorylated physiologically as shown by phosphopeptide mapping of 32 P-labelled cells and by the c-Abl-dependent induction of tyrosine phosphorylation in wild-type Hdm2 that is significantly reduced in a Y276F mutant. Moreover, we detect phosphorylation of Y276 (on endogenous Hdm2) that is coincident with the activation of c-Abl in MCF-7 cells treated with mitomycin C. These data indicate that Y276, like Y394 (Goldberg et al., 2002) , is phosphorylated physiologically by DNA damage-induced c-Abl. We also confirm that Y394 is a site of phosphorylation by c-Abl in vitro and show that Y405 may be an additional target.
Functionally, we find that a Y276F mutant of Hdm2 is more able to promote p53 turnover in the presence of Figure 3 Hdm2 is phosphorylated at Y276 in cultured cells following DNA damage. (a) COS-7 cells were transfected with plasmids encoding wild-type human Hdm2 or a Y276F mutant of Hdm2, in the presence or absence of a plasmid expressing constitutively-active nuclear c-Abl. At 48 h after transfection, the cells were labelled for 3 h with 80 MBq of [ 32 P]orthophosphate (ICN) per plate as described previously (Blattner et al., 2002) . Cell extracts were prepared and the Hdm2 proteins were immunoprecipitated, resolved by SDS-PAGE and analysed by two-dimensional chymotryptic phosphopeptide mapping (Blattner et al., 2002) . The arrow in the second panel indicates the c-Abl-dependent enhancement of a phosphopeptide from wild-type Hdm2. P marks the position to which free phosphate migrates. (b) H1299 cells were transfected with plasmids encoding wild type, or a series of mutant Hdm2 proteins, together with plasmids expressing constitutively-active or -inactive nuclear c-Abl. 48 h later, cells were treated for 30 min with 1 mM sodium orthovanadate. The Hdm2 proteins were then recovered by immunoprecipitation (antibodies SMP14 and D12) and analysed by Western blotting for phospho-tyrosine (antibody 4G10, Upstate, Dundee, UK), Hdm2 (SMP14 and D12, Santa Cruz Biotechnology, Santa Cruz, CA, USA) and c-Abl (Ab-3, Calbiochem, Merck Biosciences, Nottingham, UK). (c) H1299 cells were transfected with plasmids encoding wild type human Hdm2 in the presence or absence of a plasmid expressing constitutively-active nuclear c-Abl. After 48 h, cell extracts were prepared and analysed by Western blotting for the presence of phosphorylated Y276 (anti-Y276-P phospho-specific antibody), c-Abl (Ab-3) and Hdm2 (antibody 4B2, Moravian Biotechnology Ltd, Brno, Czech Republic). The right hand panel shows a Western blot in which unphosphorylated MP3 and MP3 phosphorylated by recombinant c-Abl kinase were used as negative and positive controls, respectively, for the anti-Y276-P phospho-specific antibody. (d) MCF-7 cells were untreated (0 h) or treated with mitomycin C (10 mg/ml) for up to 12 h. Nuclear extracts were analysed by Western blotting for Hdm2 (SMP14 and D12), phosphorylated Y276 (anti-Y276-P phospho-specific antibody) and p53 (DO-1, Santa Cruz Biotechnology). c-Abl protein kinase activity was measured in the extracts (right hand panel) using an c-Abl peptide substrate (New England Biolabs).
c-Abl phosphorylates Hdm2 at tyrosine 276 in response to DNA damage SS Dias et al active c-Abl as compared with wild-type Hdm2 (Figure  4a and b) . The ability of Y276 phosphorylation to stimulate the association of Hdm2 with its critical regulator ARF (Figure 4c ) leading to uptake of Hdm2 into the nucleolus (Figure 4d ) suggests a plausible mechanism whereby inhibition and/or sequestration of Hdm2 can promote increased p53 stability. Taken together, these effects are consistent with the idea that c-Abl, a DNA damage-activated protein kinase, relieves the inhibitory effect of Hdm2 on p53 (Sionov et al., 1999 (Sionov et al., , 2001 .
In response to DNA strand breaks, a complex series of post-translational modifications occur on p53 that is initiated and orchestrated through phosphorylation of Ser15 by ATM, leading to disruption of the p53-Hdm2 interaction and recruitment of transcriptional proteins such as p300 and CBP (Appella and Anderson, 2001; Saito et al., 2003) . Similarly, Hdm2 undergoes coincident complex changes in its post-translational modification including phosphorylation by ATM (Maya et al., 2001) , dephosphorylation of sites in the acidic domain (Blattner et al., 2002) and phosphorylation of Y394 by c-Abl (Goldberg et al., 2002) . Collectively, these changes in Hdm2 modification are thought to contribute potently to its inhibition and, consequently, to the induction of p53. The present study highlights a further mechanistic event that is likely to contribute, as part of this coordinated and complex strategy orchestrated by ATM, to the induction of p53 in response to DNA damage-inducing signals.
